Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy

Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy

Dystrophin-deficient cardiomyopathy (DDC) is currently the leading cause of death in patients with dystrophinopathies. Targeting myocardial fibrosis (MF) has become a major therapeutic goal in order to prevent the occurrence of DDC. We aimed to review and summarize the current evidence about the rol...

Full description

Bibliographic Details
Main Authors:	Moises Rodriguez-Gonzalez, Manuel Lubian-Gutierrez, Helena Maria Cascales-Poyatos, Alvaro Antonio Perez-Reviriego, Ana Castellano-Martinez
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	International Journal of Molecular Sciences
Subjects:	dystrohinopathy duchenne muscular disease becker muscular disease dystrophic deficient cardiomyopathy cardiac fibrosis renin angiotensin system
Online Access:	https://www.mdpi.com/1422-0067/22/1/356

Similar Items

Duchenne's/Becker's muscular dystrophy: Analysis of genotype-feno-type correlation in 28 patients
by: Keckarević Milica, et al.
Published: (2002-01-01)

Cardiac Magnetic Resonance Depiction of Different Morphological Appearances of Becker Cardiomyopathy in Siblings
by: Pudhiavan Arunachalam, et al.
Published: (2021-01-01)

Muscular dystrophies: key elements for everyday diagnosis and management
by: Alberto Palladino, et al.
Published: (2013-12-01)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
by: Finsterer J, et al.
Published: (2016-03-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Identification of Exonic Copy Number Variations in Dystrophin Gene Using Mlpa / Identificarea Variaţiilor Numărului de Copii în Gena Distrofinei Folosind Metoda Mlpa
by: Rusu Cristina, et al.
Published: (2014-12-01)

Molecular Characterization of Dystrophin Gene in Iraqi Patients with Muscular Dystrophy.
by: Areen T. Ramadhan Al-Hadithi, et al.
Published: (2014-07-01)

Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine
by: Domenico D’Amario, et al.
Published: (2018-09-01)

Carrier detection of duchenne and becker muscular dystrophy using muscle dystrophin immunohistochemistry
by: Acary S. Bulle Oliveira, et al.
Published: (1992-12-01)

Membrane Sealant Poloxamer P188 Protects Against Isoproterenol Induced Cardiomyopathy in Dystrophin Deficient Mice
by: Sali Arpana, et al.
Published: (2011-05-01)

Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy
by: Tatyana A. Meyers, et al.
Published: (2019-08-01)

Duchenne and Becker muscular dystrophy: implications for at-risk individuals
by: Erasmus, Suretha
Published: (2010)

A case of Becker muscular dystrophy with early manifestation of cardiomyopathy
by: Ki Hyun Doo, et al.
Published: (2012-09-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Comprehensive genetic characteristics of dystrophinopathies in China
by: Peipei Ma, et al.
Published: (2018-07-01)

Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture
by: Keryn G. Woodman, et al.
Published: (2016-11-01)

Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy
by: Xu X, et al.
Published: (2021-04-01)

Atualização do tratamento fisioterapêutico das distrofias musculares de Duchenne e de Becker - doi:10.5020/18061230.2005.p41
by: Simone Rizzo Nique da Silva, et al.
Published: (2012-01-01)

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin
by: Ken’ichiro Nogami, et al.
Published: (2020-07-01)

Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy
by: Salvo Danilo Lombardo, et al.
Published: (2019-11-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach Distrofia muscular de Duchenne e Becker: abordagem molecular e imuno-histoquímica
by: Aline Andrade Freund, et al.
Published: (2007-03-01)

Adequate managment of patients with dystrophinopathies (muscular dystrophy Duchenne/Becker): objective scales and additional diagnostic methods
by: A. S. Nosko, et al.
Published: (2015-02-01)

MLPA followed by target‐NGS to detect mutations in the dystrophin gene of Peruvian patients suspected of DMD/DMB
by: María Luisa Guevara‐Fujita, et al.
Published: (2021-09-01)

Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril
by: Sophie Mavrogeni, et al.
Published: (2017-07-01)

Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging
by: Zhang L, et al.
Published: (2015-12-01)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01)

Motor clinical progression in a series of pediatric Duchenne and Becker muscular dystrophy cases
by: Zakiah Nur Istianah, et al.
Published: (2019-03-01)

Duchenne and Becker muscular dystrophy in adolescents: current perspectives
by: Andrews JG, et al.
Published: (2018-03-01)

Perceived quality of life among caregivers of children with a childhood-onset dystrophinopathy: a double ABCX model of caregiver stressors and perceived resources
by: Frishman, Natalia, et al.
Published: (2017)

Assessment of the structural and functional impact of in-frame mutations of the <it>DMD</it> gene, using the tools included in the eDystrophin online database
by: Nicolas Aurélie, et al.
Published: (2012-07-01)

The dystrophinopathies in Costa Rica
by: Jorge Azofeifa
Published: (2004-09-01)

Relevant aspects of golden retriever muscular dystrophy for the study of Duchenne muscular dystrophy in humans
by: Julieta Rodini Engrácia de Moraes, et al.
Published: (2017-09-01)

Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model
by: Rachel T. Sullivan, et al.
Published: (2021-06-01)

Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies
by: Kenji Rowel Q. Lim, et al.
Published: (2020-07-01)

Quantitative analysis of the dystrophin gene by real-time PCR
by: Maksimovic Nela, et al.
Published: (2012-01-01)

Mending a Broken Heart: The Role of Sarcospan in Duchenne Muscular Dystrophy–Associated Cardiomyopathy
by: Richard S. Vander Heide
Published: (2015-12-01)

Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model
by: Du, Y., et al.
Published: (2022)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018-08-01)

Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study
by: Liang Wang, et al.
Published: (2017-05-01)

Cannot write session to /tmp/vufind_sessions/sess_g243ia1hdkrj8dk6hf9ao2j43p